Cleared Traditional

K082586 - LIGHTWAVE PROFESSIONAL DELUXE

K082586 is an FDA 510(k) clearance for LIGHTWAVE PROFESSIONAL DELUXE, manufactured by Lightwave Technologies, LLC. The device is a Class 2 General & Plastic Surgery device with product code GEX cleared through the Traditional 510(k) pathway after a 483-day FDA review.

K082586 · Lightwave Technologies, LLC · General & Plastic Surgery device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 2010
Decision
483d
Days
Class 2
Risk

K082586 is an FDA 510(k) clearance for the LIGHTWAVE PROFESSIONAL DELUXE. Classified as Powered Laser Surgical Instrument within the GEX classification (a category for powered laser surgical instruments across multiple specialties), Class II - Special Controls.

Submitted by Lightwave Technologies, LLC (Great Neck, US). The FDA issued a Cleared decision on January 4, 2010 after a review of 483 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 878.4810 - the FDA general and plastic surgery device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind General & Plastic Surgery submissions.

View all Lightwave Technologies, LLC devices

FDA 510(k) Submission Details - K082586

510(k) Number K082586 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 08, 2008
Decision Date January 04, 2010
Days to Decision 483 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
368d slower than avg
Panel avg: 115d · This submission: 483d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GEX Device Classification - Class 2, Special Controls

Product Code GEX Powered Laser Surgical Instrument
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 878.4810
Definition A Laser (light Amplification By Stimulated Emission Of Radiation) Based Device Having Coherence, Collimated And Typically Monochromatic Radiation. Typically Indicated To To Cut, Destroy, Remove Or Coagulate Tissue, Generally Soft Tissue, For General Surgical Purpose In Medical Specialties Of General And Plastic Surgery, Dermatology/aesthetic, Podiatry, Otolaryngology (ent), Gynecology, Neurosurgery, Orthopedics (soft Tissue), Dental And Oral Surgery, And Dentistry. The Classification Regulation 21 Cfr 878.4810 Describes A Device That Is Carbon Dioxide Or Argon Laser Intended To Cut, Destroy, Remove Or Coagulate Tissue By The Light.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General & Plastic Surgery devices follow this clearance model.

Regulatory Peers - GEX Powered Laser Surgical Instrument

All 1841
Devices cleared under the same product code (GEX) and FDA review panel - the closest regulatory comparables to K082586.
VECTRA PLUS LASER SYSTEM AND ACCESSORIES
K082230 · Xintec Corporation · Feb 2010
FIDELIS PLUS III D, AT FIDELIS D, POWERLASE AT D / FIDELIS PLUS III, AT FIDELIS, POWERLASE AT / FIDELIS ER III D, HT FID
K093162 · Fotona D.D. · Jan 2010
VARI-LASE ENDOVENOUS LASER CONSOLE
K093502 · Vascular Solutions, Inc. · Jan 2010
COOLTOUCH VARIA ND:YAG LASER SYSTEM
K092964 · New Star Lasers, Inc. · Dec 2009
ACCUMAX
K093691 · Boston Scientific Corp · Dec 2009
WATERLASE MD, MODEL 7100102
K091746 · Biolase Technology, Inc. · Dec 2009